Doug Schenkel
Stock Analyst at Wolfe Research
(3.62)
# 788
Out of 4,865 analysts
66
Total ratings
54.17%
Success rate
35.02%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Outperform | $60 | $68.86 | -12.87% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $64.25 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $33.92 | +76.89% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $23.88 | +17.25% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $218.06 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $119.00 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $2.09 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $194.17 | +46.78% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $37.50 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $114.90 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $46.40 | +10.99% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $10.56 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $89.55 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $52.30 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $385.87 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.97 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $93.20 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.27 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $13.04 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $49.52 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $167.28 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $338.29 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.00 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.67 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.81 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.35 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.98 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.56 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.26 | +698.23% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $20.07 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $304.39 | -70.43% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.14 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $219.55 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $81.31 | -80.32% | 2 | Sep 28, 2017 |
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $68.86
Upside: -12.87%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $64.25
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $33.92
Upside: +76.89%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $23.88
Upside: +17.25%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $218.06
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $119.00
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $2.09
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $194.17
Upside: +46.78%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $37.50
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $114.90
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $46.40
Upside: +10.99%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $10.56
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $89.55
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $52.30
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $385.87
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $4.97
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $93.20
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.27
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $13.04
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $49.52
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $167.28
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $338.29
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.00
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.67
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.81
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.35
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.98
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $3.56
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.26
Upside: +698.23%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $20.07
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $304.39
Upside: -70.43%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $6.14
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $219.55
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $81.31
Upside: -80.32%